French AI software company Sonio has raised €10M fundraising through the European Innovation Council Accelerator.
Sonio supports foetal medicine professionals and secures pregnancy ultrasounds through AI.
This fundraising (€2.5M in grant and €7.5M in equity investment) follows the €5M raised with Elaia, OneRagtime and Bpi France in June this year.
The investment will enable Sonio to accelerate the release of new features on the platform, such as embedded image recognition and genomics.
It will also support the French startup’s market entry in the USA, as well as ramp up sales in Europe and India.
Cécile Brosset, Chief Executive Officer and co-Founder of Sonio, said:
“Receiving such a significant funding from one of the most competitive accelerators in the world is a testament to the innovation Sonio brings to fetal medicine.
“Our hard work has been fruitful.
“I am now more confident than ever that we can help secure pregnancy care worldwide with collective and artificial intelligence.”
Sonio brings together unique expertise from the fields of foetal medicine, AI, software development and ultrasound imaging to address the 50 per cent of congenital malformations that are not detected before birth and improve access and quality of care for pregnant women and children.
Its solution can assist all foetal ultrasound practitioners, from beginners to the most seasoned experts and is already being used by over 250 healthcare professionals.
Rémi Besson, Chief Scientific Officer and co-Founder of Sonio.
“For us this funding means more research, more clinical studies, more innovation, more patents filed in Europe and ultimately an improved quality of care for patients, wherever they are.
“We are eager to intensify our scientific partnerships with some of the best experts in Foetal Medicine and Artificial Intelligence.”
Sonio has already brought two products to market.
The CE-marked Sonio Diagnostics, designed for expert diagnostic ultrasounds, and Sonio Pro, tailored to bring more efficiency to routine pregnancy ultrasounds.